Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Sinus Aspiration against Contrast Induced Kidney Injury: Yes or No?

Sinus Aspiration against Contrast Induced Kidney InjuryContrast induced kidney injury incidence is in direct correlation to the administered contrast. The aim of this study was to assess the safety and efficacy of sinus aspiration immediately after PCI as a measure to reduce the volume of contrast arriving in the kidneys.

 

The study included 43 patients with diabetes and renal impairment (creatinine between 1.5 and 3 mg/dL) that were candidates for a coronary angiography.

 

Sinus aspiration was performed in 18 patients out of 43, and the rest served as control group. All patients received periprocedural standard care.

 

Aspiration was done directly from a trans-septal sheath via femoral or subclavian approach in 8 patients; other 10 patients were accessed through a balloon occlusion catheter placed through the sheath simultaneously during coronary angiography.

 

The estimated contrast volume aspirated was based on the reduction in hematocrit value of the aspirate (reduced by contrast) in relation to the patient’s baseline hematocrit.  Fraction of aspirated contrast was calculated by dividing the estimated volume of aspirated contrast over the volume of injected contrast multiplied by 100.

 

Both the group receiving coronary sinus aspiration and the control group resulted similar as to clinical and lab characteristics, as well as administered contrast.

 

In the active group, aspirated contrast fraction was 39.35 ± 10.47%. Only one patient in the coronary sinus aspiration group, vs. 9 patients in the control group, presented contrast induced kidney injury (p=0.028).

 

Conclusion

Coronary sinus aspiration during coronary angiography can effectively remove up to a third of the administered contrast, reducing contrast kidney injury in selected patients.

 

Editorial Comment

This maneuver appears to be simple and logical; in fact, after reading Dr Diab’s work, most of us might have thought “how come we didn’t think of this before”.

 

This study does not report important complications, and contrast induced kidney injury reduction rate is quite significant; however, more definite conclusions call for a larger, more important study.

 

Original Title: Efficacy and Safety of Coronary Sinus Aspiration during Coronary Angiography to Attenuate the Risk of Contrast-Induced Acute Kidney Injury in Predisposed Patients.

Reference: Osama Ali Diab et al. Circ Cardiovasc Interv. 2017 Jan;10(1):e004348.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

GLUCO-TAVI | Can Glucocorticoids Reduce the Need for Permanent Pacemaker Implantation After TAVI?

Despite the expansion of transcatheter aortic valve implantation (TAVI) indications, cardiac conduction disturbances (CCD) and the need for permanent pacemaker implantation (PPI) remain the...

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...